THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Under big biotech's wing

On mission for innovation, Biogen Idec opens incubator

By Todd Wallack
Globe Staff / December 19, 2007

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Like other major biotechnology companies, Biogen Idec Inc. has a cadre of talented scientists working feverishly to discover breakthrough drugs. Over the years, the Cambridge biotech has also made acquisitions, established a $105 million venture fund, and licensed promising technologies to build a pipeline of potential life-saving therapies. (Full article: 797 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass